Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2012 by The Catholic University of Korea
Sponsor:
Information provided by (Responsible Party):
Myung-gui Choi, The Catholic University of Korea
ClinicalTrials.gov Identifier:
NCT01659632
First received: August 6, 2012
Last updated: NA
Last verified: August 2012
History: No changes posted
  Purpose

Most of the early gastric cancer are asymptomatic. Symptoms of advanced gastric cancer are weight loss, abdominal pain, nausea, vomiting, anorexia dysphagia, gastrointestinal bleeding. Gastric cancer found according to warning symptoms such as gastrointestinal bleeding, weight loss usually can not be cured. Therefore, early gastric cancer can not be detected and impossible to treatment if endoscopy is performed according to the warning signs. National gastric cancer screening is conducted in men and women of more than 40 years old. The purpose of screening for gastric cancer is discovering a case of possible cure, so increasing the survival rate. The purpose of this study is review of the feasibility of screening for gastric cancer.


Condition
Early Gastric Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer

Resource links provided by NLM:


Further study details as provided by The Catholic University of Korea:

Estimated Enrollment: 1000
Study Start Date: April 2010
Estimated Study Completion Date: March 2014
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   15 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

gastric cancer patients in St.mary`s hospital

Criteria

Inclusion Criteria:

  • gastric cancer patients in St.mary`s hospital

Exclusion Criteria:

  • gastric lymphoma, gastric GIST patients in St.mary`s hospital
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01659632

Contacts
Contact: eunyoung park, MD peyoung97@hanmail.net

Locations
Korea, Republic of
St. mary`s hospital Recruiting
Seoul, Korea, Republic of
Sponsors and Collaborators
The Catholic University of Korea
  More Information

No publications provided

Responsible Party: Myung-gui Choi, Professor, The Catholic University of Korea
ClinicalTrials.gov Identifier: NCT01659632     History of Changes
Other Study ID Numbers: gastric cancer alarm symptom
Study First Received: August 6, 2012
Last Updated: August 6, 2012
Health Authority: Korea: Institutional Review Board

Additional relevant MeSH terms:
Stomach Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Stomach Diseases

ClinicalTrials.gov processed this record on July 22, 2014